FDA Issues Alert on Edwards Lifesciences Mitral Valve Delivery System Due to Balloon Malfunctions

The FDA has issued an Early Alert, recommending the removal of specific Edwards Lifesciences SAPIEN M3 transcatheter mitral valve delivery systems. This action follows three reports of balloons bursting during inflation, which could lead to serious patient injuries such as embolism and device retrieval failure, raising significant safety concerns.